CoreAge Rx vs Injectco
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Injectco head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Injectco a bad call — it's best for readers who want a clinic-based option and can confirm which local or virtual program, medication and package terms apply. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Injectco |
|---|---|---|
| Brief Score | 94/100 (A) | 65/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Dallas: $425/month Or $1,800 upfront for 6–8 months; location-specific compounded program. Separate $1,249 starting-dose GLP-1 package does not identify the drug; confirm which offer applies. Full price detailsProgram quote varies by location; Dallas lists $425/month or $1,800 upfront for 6–8 months of compounded semaglutide; separate $1,249 starting-dose GLP-1 package does not identify the medication |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Dallas: $425/month Or $1,800 upfront for 6–8 months; location-specific compounded program. Separate $1,249 starting-dose GLP-1 package does not identify the drug; confirm which offer applies. Full price detailsProgram quote varies by location; Dallas lists $425/month or $1,800 upfront for 6–8 months of compounded tirzepatide; separate $1,249 starting-dose GLP-1 package does not identify the medication |
| Coverage | US only; restrictions by state, confirmed at intake | Texas clinics and a Louisiana virtual program are described; complete medication-specific state eligibility is not established. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Injectco: Dallas publishes monthly and upfront options. The separate starting-dose package has different terms; get the named prescription and expected supply in writing.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.